BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31507329)

  • 1. A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexate.
    Reed DR; Pierce EJ; Sen JM; Keng MK
    Cancer Manag Res; 2019; 11():8065-8072. PubMed ID: 31507329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization.
    Heisler RD; Kelly JJ; Abedinzadegan Abdi S; Hawker JL; Fong LG; Quon JL; Rioux JZ; Jupp JC
    Support Care Cancer; 2022 Feb; 30(2):1273-1281. PubMed ID: 34471970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the impact of adding acetazolamide to oral or intravenous sodium bicarbonate as compared with intravenous bicarbonate monotherapy as urinary alkalinization in adults receiving high-dose methotrexate.
    Clemmons AB; Chase A; Duong P; Waller JL; Saunders K; Bryan L
    Support Care Cancer; 2021 Mar; 29(3):1527-1534. PubMed ID: 32725375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of methotrexate clearance with an enteral urine alkalinization protocol for patients receiving high-dose methotrexate.
    Kramer E; Filtz M; Pace M
    J Oncol Pharm Pract; 2021 Jan; 27(1):26-32. PubMed ID: 32164493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Methods of Urinary Alkalinization for High-dose Methotrexate Administration: Alternatives to Intravenous Sodium Bicarbonate During a Critical Drug Shortage.
    Visage R; Kaiser N; Williams M; Kim A
    J Pediatr Hematol Oncol; 2019 Jul; 41(5):371-375. PubMed ID: 30475303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective evaluation of sodium acetate use for urine alkalinization in patients receiving high dose methotrexate.
    Perkey CL; Flynn LA; Lentz K; Butler S
    J Oncol Pharm Pract; 2023 Jan; 29(1):119-124. PubMed ID: 34931924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Receiving High-Dose Methotrexate.
    Drost SA; Wentzell JR; Giguère P; McLurg DL; Sabloff M; Kanji S; Nguyen TT
    Pharmacotherapy; 2017 Jun; 37(6):684-691. PubMed ID: 28394433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced time for urinary alkalinization before high-dose methotrexate with preadmission oral bicarbonate.
    Kintzel PE; Campbell AD; Yost KJ; Brinker BT; Arradaza NV; Frobish D; Wehr AM; O'Rourke TJ
    J Oncol Pharm Pract; 2012 Jun; 18(2):239-44. PubMed ID: 22075004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do intravenous fluid substitutions influence methotrexate clearance? An unanticipated impact of an intravenous sodium bicarbonate drug shortage.
    Mangum R; Bernhardt MB; Cheng WS; Schafer ES; Berg SL; Foster JH
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28334. PubMed ID: 32608575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization: A pediatric experience.
    Diachinsky M; Tran T; Jupp J; McKinnon K
    J Oncol Pharm Pract; 2021 Jan; 27(1):119-127. PubMed ID: 32316877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral regimen for high dose methotrexate urine alkalinization: a systematic review and meta-analysis.
    Kaveh-Ahangaran R; Abdollahi M; Vaezi M; Kasaeian A; Bahlouli Z; Janbabaei G; Mojtahedzadeh A; Mojtahedzadeh M; Djalalinia S; Shahrami B
    Daru; 2024 Jun; 32(1):353-377. PubMed ID: 38233724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of a urine alkalinization protocol developed for high-dose methotrexate patients during intravenous bicarbonate shortage.
    Roy AM; Lei M; Lou U
    J Oncol Pharm Pract; 2019 Dec; 25(8):1860-1866. PubMed ID: 30636529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of citrate mixture vs sodium bicarbonate on urine alkalization in Chinese primary gout patients with benzbromarone: a prospective, randomized controlled study.
    Xue X; Liu Z; Li X; Lu J; Wang C; Wang X; Ren W; Sun R; Jia Z; Ji X; Chen Y; He Y; Ji A; Sun W; Zhang H; Merriman TR; Li C; Cui L
    Rheumatology (Oxford); 2021 Jun; 60(6):2661-2671. PubMed ID: 33211886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of low dose acetazolamide as an adjunct in patients undergoing high dose methotrexate is safe and beneficial.
    Ku M; Bazargan A; Tam C
    Intern Med J; 2020 Mar; 50(3):357-362. PubMed ID: 31403755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of enteral and parenteral methods of urine alkalinization in patients receiving high-dose methotrexate.
    Rouch JA; Burton B; Dabb A; Brown V; Seung AH; Kinsman K; Holdhoff M
    J Oncol Pharm Pract; 2017 Jan; 23(1):3-9. PubMed ID: 26467268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetazolamide for acute kidney injury in patients undergoing high dose methotrexate therapy: a systematic review and meta-analysis.
    Truong HH; Reddy S; Charkviani M; Nikravangolsefid N; Ninan J; Hassett L; Kashani KB; Domecq JP
    J Nephrol; 2024 Jan; ():. PubMed ID: 38265601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does sodium bicarbonate infusion really have no effect on the incidence of acute kidney injury after cardiac surgery? A prospective observational trial.
    Wetz AJ; Bräuer A; Quintel M; Heise D
    Crit Care; 2015 Apr; 19(1):183. PubMed ID: 25899029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single assessment of methotrexate levels at 42 hours permits safe administration and early discharge in children with lymphoblastic lymphoma and leukemia receiving high-dose methotrexate.
    Totadri S; Srinivasan HN; Joseph LL; Boddu D; Mathew LG; John R
    Pediatr Hematol Oncol; 2021 Aug; 38(5):434-443. PubMed ID: 33764242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison potassium sodium hydrogen citrate with sodium bicarbonate in urine alkalization: a prospective crossover-controlled trial.
    Xue W; Cheng J; Zhao J; Wang L; Peng A; Liu X
    Int Urol Nephrol; 2023 Jan; 55(1):61-68. PubMed ID: 36261757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients.
    Mosleh E; Snyder S; Wu N; Willis DN; Malone R; Hayashi RJ
    Front Oncol; 2023; 13():1280587. PubMed ID: 37965460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.